Affiliation:
1. Department of Obstetrics, Gynecology and Reproductive Sciences University of California, San Diego La Jolla California USA
2. School of Medicine University of California, San Diego La Jolla California USA
3. Division of Reproductive Endocrinology and Infertility Department of Obstetrics, Gynecology and Reproductive Sciences Moores Cancer Center University of California, San Diego La Jolla California USA
Abstract
AbstractFertility is a top concern for many survivors of cancer diagnosed as children, adolescents and young adults (CAYA). Fertility preservation (FP) treatments are effective, evidence‐based interventions to support their family building goals. Fertility discussions are a part of quality oncology care throughout the cancer care continuum. For nearly 2 decades, clinical guidelines recommend counseling patients about the possibility of infertility promptly at diagnosis and offering FP options and referrals as indicated. Multiple guidelines now recommend post‐treatment counseling. Infertility risks differ by cancer treatments and age, rendering risk stratification a central part of FP care. To support FP decision‐making, online tools for female risk estimation are available. At diagnosis, females can engage in mature oocyte/embryo cryopreservation, ovarian tissue cryopreservation, ovarian suppression with GnRH agonists, in vitro oocyte maturation, and/or conservative management for gynecologic cancers. Post‐treatment, several populations may consider undergoing oocyte/embryo cryopreservation. Male survivors’ standard of care FP treatments center on sperm cryopreservation before cancer treatment and do not have the same post‐treatment indication for additional gamete cryopreservation. In practice, FP care requires systemized processes to routinely screen for FP needs, bridge oncology referrals to fertility, offer timely fertility consultations and access to FP treatments, and support financial navigation. Sixteen US states passed laws requiring health insurers to provide insurance benefits for FP treatments, but variation among the laws and downstream implementation are barriers to accessing FP treatments. To preserve the reproductive futures of CAYA survivors, research is needed to improve risk stratification, FP options, and delivery of FP care.
Reference100 articles.
1. American Cancer Society.Cancer Facts & Figures 2022. Accessed December 20 2022.https://www.cancer.org/content/dam/cancer‐org/research/cancer‐facts‐and‐statistics/annual‐cancer‐facts‐and‐figures/2022/2022‐cancer‐facts‐and‐figures.pdf
2. American Cancer Society.Cancer Facts & Figures 2020‐Special Section: Cancer in Adolescents and Young Adults.2023.https://www.cancer.org/content/dam/cancer‐org/research/cancer‐facts‐and‐statistics/annual‐cancer‐facts‐and‐figures/2020/special‐section‐cancer‐in‐adolescents‐and‐young‐adults‐2020.pdf
3. Fertility preservation knowledge, counseling, and actions among adolescent and young adult patients with cancer: A population-based study
4. Early information needs of adolescents and young adults about late effects of cancer treatment
5. Taboo Topics in Adolescent and Young Adult Oncology: Strategies for Managing Challenging but Important Conversations Central to Adolescent and Young Adult Cancer Survivorship
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献